Beyond Clinical Success,
Commercial Certainty

Gaide is an AI-powered platform that translates complex payer logic into quantitative insights to maximize commercial success and ensure that life-changing medicines reach the patients they were built for.

The Scale of Intelligence

Evidence-Based. Data-Backed. Battle-Tested.

Our models are not hallucinating; they are referencing a massive, structured dataset of historical reality.

20+
Years of Clinical Guidelines
tracked for semantic evolution
15,000+
HTA Decisions
(G-BA, HAS, NICE) ingested and labeled
120,000+
Clinical Trials
analyzed for comparator and endpoint trends
2,500+
Proprietary Features
engineered per therapeutic indication
94%
Prediction Accuracy
verified against historical payer decisions
Expertise

Our Solutions

Unifying clinical strategy and market reality to maximize asset value.

Clinical Development

Embed commercial viability into trial design. Move beyond regulatory compliance by integrating payer logic into your protocols, ensuring your clinical evidence secures future reimbursement.

Explore Protocol Engineering

Market Access

Maximize revenue potential with predictive certainty. Replace guesswork with quantitative foresight to de-risk HTA submissions, accelerate time-to-market, and secure the optimal price for your therapy.

Advance Market Strategy

Our Platform

A proprietary System of Intelligence. Powered by an orchestrated hive of specialized AI Micro-Agents, we translate qualitative regulatory text into computable vectors—turning "regulatory intuition" into math. By simulating the distinct decision logic of national HTA bodies, our system transforms complex data into a single, commercially actionable strategy.

Explore the Platform
HTA Decisions
Historical Outcomes
Clinical Guidelines
Regulatory Standards
Trial Data
Evidence & Endpoints
Endpoint Vector
Pop. Alignment
Stat. Robustness
Endpoint Acceptance
Comparator Alignment
Subgroup Relevance
Ensemble
Layer
Forecasted
Outcome
Evidence-Backed Confidence

Value by Lifecycle

Value by Lifecycle Continuous commercial foresight. From Phase I design to final pricing negotiations, gaide embeds market reality into every stage of clinical development—ensuring your asset's value compounds with every decision.

See Value at Every Stage
01

Early-Stage Development

Pre-Clinical & Phase I

We align clinical strategy with commercial viability before the most expensive investments are made.

02

Clinical Development

Phase II & Phase III

Navigating high-stakes decisions where errors are irreversible. Determining the correct trials design.

03

Post-Market Authorization

Launch & Life Cycle

Strategies for label expansion and price defense to maximize total lifetime value.